CN109844538A - 用于增强荧光的组合物和方法 - Google Patents

用于增强荧光的组合物和方法 Download PDF

Info

Publication number
CN109844538A
CN109844538A CN201780062491.4A CN201780062491A CN109844538A CN 109844538 A CN109844538 A CN 109844538A CN 201780062491 A CN201780062491 A CN 201780062491A CN 109844538 A CN109844538 A CN 109844538A
Authority
CN
China
Prior art keywords
alexa
dylight
antibody
fluorescent
spacer molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780062491.4A
Other languages
English (en)
Chinese (zh)
Inventor
S·德塞
M·恩兰德
K·吉
M·贝克
R·阿吉勒
S·斯维尼
A·卢卡维什尼科夫
S-J·黄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierce Biotechnology Inc
Life Technologies Corp
Original Assignee
Pierce Biotechnology Inc
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierce Biotechnology Inc, Life Technologies Corp filed Critical Pierce Biotechnology Inc
Publication of CN109844538A publication Critical patent/CN109844538A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0015—Phosphorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Electroluminescent Light Sources (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201780062491.4A 2016-09-01 2017-09-01 用于增强荧光的组合物和方法 Pending CN109844538A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662382594P 2016-09-01 2016-09-01
US62/382,594 2016-09-01
PCT/US2017/049838 WO2018045278A1 (en) 2016-09-01 2017-09-01 Compositions and methods for enhanced fluorescence

Publications (1)

Publication Number Publication Date
CN109844538A true CN109844538A (zh) 2019-06-04

Family

ID=59846737

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780062491.4A Pending CN109844538A (zh) 2016-09-01 2017-09-01 用于增强荧光的组合物和方法

Country Status (6)

Country Link
US (4) US20180092993A1 (cg-RX-API-DMAC7.html)
EP (2) EP3507603B1 (cg-RX-API-DMAC7.html)
JP (4) JP7216638B2 (cg-RX-API-DMAC7.html)
CN (1) CN109844538A (cg-RX-API-DMAC7.html)
ES (1) ES2979129T3 (cg-RX-API-DMAC7.html)
WO (1) WO2018045278A1 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113913404A (zh) * 2020-07-10 2022-01-11 上海米然生物科技有限公司 一种荧光交联RNase H突变体缀合物及其应用
WO2023088402A1 (zh) * 2021-11-22 2023-05-25 菲鹏生物股份有限公司 一种捕获法检测抗体的方法和应用

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3019559A4 (en) 2013-08-22 2017-04-05 Sony Corporation Water soluble fluorescent or colored dyes and methods for their use
BR112018070164B1 (pt) 2016-04-01 2022-09-27 Sony Corporation Of America Corantes diméricos ou poliméricos ultrabrilhantes
CN109153860B (zh) 2016-04-06 2021-04-23 索尼公司 具有间隔连接体基团的超高亮二聚体或聚合物染料
BR112018073199A2 (pt) 2016-05-11 2019-04-16 Sony Corporation corantes diméricos ou poliméricos ultrabrilhantes
WO2018022925A1 (en) 2016-07-29 2018-02-01 Sony Corporation Ultra bright dimeric or polymeric dyes and methods for preparation of the same
EP3507603B1 (en) * 2016-09-01 2024-03-06 Life Technologies Corporation Compositions and methods for enhanced fluorescence
KR102795781B1 (ko) 2017-06-16 2025-04-15 듀크 유니버시티 개선된 라벨 검출, 계산, 분석물 감지, 및 조정 가능한 난수 생성을 위한 공진기 네트워크
US12290571B2 (en) 2017-10-05 2025-05-06 Sony Group Corporation Programmable dendritic drugs
KR20260011205A (ko) 2017-10-05 2026-01-22 소니그룹주식회사 프로그램가능한 중합체성 약물
CN111836645A (zh) 2017-11-16 2020-10-27 索尼公司 可编程的聚合药物
US20190154669A1 (en) * 2017-11-20 2019-05-23 Vector Laboratories, Inc. Methods and systems for species-on-species immunoassay detection
EP3737417B1 (en) 2018-01-12 2025-08-27 Sony Group Corporation Phosphoalkyl ribose polymers comprising biologically active compounds
US12076407B2 (en) 2018-01-12 2024-09-03 Sony Group Corporation Polymers with rigid spacing groups comprising biologically active compounds
WO2019140128A1 (en) 2018-01-12 2019-07-18 Sony Corporation Phosphoalkyl polymers comprising biologically active compounds
EP3769085B1 (en) * 2018-03-19 2022-08-24 Sony Group Corporation Use of divalent metals for enhancement of fluorescent signals
KR102864292B1 (ko) 2018-03-21 2025-09-26 소니그룹주식회사 링커 군을 갖는 중합체성 텐덤 염료
CN112384573A (zh) 2018-03-30 2021-02-19 贝克顿·迪金森公司 含侧基发色团的水溶性聚合染料
JP7580689B2 (ja) 2018-06-27 2024-11-12 ソニーグループ株式会社 デオキシリボースを含むリンカー基を有するポリマー色素
CN109086566B (zh) * 2018-07-12 2021-06-18 浙江工业大学 一种基于片段重采样的群体蛋白质结构预测方法
US12578342B2 (en) 2018-07-13 2026-03-17 Sony Group Corporation Polymeric dyes having a backbone comprising organophosphate units
JP2022533145A (ja) * 2019-05-13 2022-07-21 シャンハイ ポラリス バイオロジー カンパニー， リミテッド 生体分子を標識するためのタグ
WO2020255906A1 (ja) * 2019-06-20 2020-12-24 コニカミノルタ株式会社 蛍光標識剤用連結体
EP3861074A2 (en) 2019-09-26 2021-08-11 Sony Group Corporation Polymeric tandem dyes with linker groups
EP4038081A1 (en) 2019-09-30 2022-08-10 Sony Group Corporation Nucleotide probes
CN115023611A (zh) * 2020-03-25 2022-09-06 积水医疗株式会社 免疫学分析方法和免疫学分析试剂盒
US11408825B2 (en) 2020-08-28 2022-08-09 Hong Kong Applied Science and Technology Research Institute Company Limited Forensic detector and the system thereof
US12203914B2 (en) 2020-11-12 2025-01-21 Sartorius Bioanalytical Instruments, Inc. Viral clearance evaluation for biological medical product preparation processes
EP4256078A1 (en) 2020-12-07 2023-10-11 Sony Group Corporation Spacing linker group design for brightness enhancement in dimeric or polymeric dyes
WO2023032994A1 (ja) * 2021-08-31 2023-03-09 富士フイルム株式会社 化合物及びこれを用いた標識生体物質
CN115466960B (zh) * 2022-09-15 2023-05-26 河北工业大学 一种含苯并噻唑基团改性聚天冬氨酸荧光缓蚀剂的制备方法和应用
CN120380327A (zh) * 2022-12-26 2025-07-25 富士胶片株式会社 荧光强度增强剂、经荧光标记的靶标生物物质的荧光强度增强方法及荧光检测用试剂盒
CN117168937A (zh) * 2023-09-01 2023-12-05 河南赛诺特生物技术有限公司 一种延缓荧光淬灭的封片组合物、封片剂及其应用
WO2025182762A1 (ja) * 2024-02-29 2025-09-04 富士レビオ株式会社 検出方法、並びに、これに用いる標識体及びキット
US20250341516A1 (en) * 2024-05-01 2025-11-06 BioLegend, Inc. Compositions for use with multiple fluorophores and methods of using

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1832762A (zh) * 2003-08-08 2006-09-13 弗雷泽纽斯卡比德国有限公司 羟烷基淀粉与g－csf的偶联物
US20060234229A1 (en) * 2002-06-03 2006-10-19 Van Beuningen Marinus G J Novel method for monitoring biomolecular interactions
CN101790684A (zh) * 2007-06-14 2010-07-28 创新生物科学有限公司 缀合物制备的改进或与缀合物制备相关的改进
CN101827946A (zh) * 2007-05-18 2010-09-08 茵维特罗根公司 快速蛋白质标记和分析
CN101946171A (zh) * 2007-12-14 2011-01-12 拜奥蒂乌姆股份有限公司 荧光化合物
CN102692508A (zh) * 2012-04-28 2012-09-26 广州鸿琪光学仪器科技有限公司 一种快速定量检测肌钙蛋白t的免疫荧光试纸条组件及其制成的检测卡组件和制备方法
CN103328532A (zh) * 2010-01-19 2013-09-25 赛里根Ii有限公司 用于定向生物标志信号放大的新颖试剂
US20140206099A1 (en) * 2012-09-18 2014-07-24 Biotium, Inc. Methods, compositions and kits for labeling of proteins

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459272A (en) 1990-10-16 1995-10-17 Research Corporation Technologies Quinoline-2-(carboxaldehyde) reagents for detection of primary amines
US6706879B2 (en) 2001-02-28 2004-03-16 Stratagene Fluorescent dye
US6972326B2 (en) 2001-12-03 2005-12-06 Molecular Probes, Inc. Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes
WO2007120762A2 (en) * 2006-04-14 2007-10-25 Cambrios Technologies Corporation Fluorescent particles bound to multifunctional scaffolds and their uses
US9127130B2 (en) 2006-08-11 2015-09-08 Starpharma Pty Ltd. Polylysine dendrimer contrast agent
JP5540964B2 (ja) 2010-07-23 2014-07-02 コニカミノルタ株式会社 蛍光標識剤、並びにこれを用いた結合体及びバイオアッセイ法
US9448173B2 (en) 2011-03-08 2016-09-20 The Board Of Trustees Of The University Of Illinois Dye-conjugated dendrimers
US20130052130A1 (en) 2011-08-30 2013-02-28 University Of Washington Branched Discreet PEG Constructs
US8835000B2 (en) 2011-12-23 2014-09-16 General Electric Company High-density fluorescent dye clusters
AU2013229631B2 (en) 2012-03-05 2017-09-14 Bracco Imaging Spa Dynamic Contrast Enhanced MRI method and agents for the assessment of the macromolecular transport within pathologic tissues
WO2014138186A1 (en) * 2013-03-05 2014-09-12 The Johns Hopkins University Bioorthogonal two-component delivery systems for enhanced internalization of nanotherapeutics
US9670318B2 (en) 2015-05-28 2017-06-06 Miltenyi Biotec Gmbh Bright fluorochromes based on multimerization of fluorescent dyes
EP3507603B1 (en) * 2016-09-01 2024-03-06 Life Technologies Corporation Compositions and methods for enhanced fluorescence
WO2018045275A1 (en) 2016-09-01 2018-03-08 Nike Innovate C.V. Vented garment

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060234229A1 (en) * 2002-06-03 2006-10-19 Van Beuningen Marinus G J Novel method for monitoring biomolecular interactions
CN1832762A (zh) * 2003-08-08 2006-09-13 弗雷泽纽斯卡比德国有限公司 羟烷基淀粉与g－csf的偶联物
CN101827946A (zh) * 2007-05-18 2010-09-08 茵维特罗根公司 快速蛋白质标记和分析
CN101790684A (zh) * 2007-06-14 2010-07-28 创新生物科学有限公司 缀合物制备的改进或与缀合物制备相关的改进
CN101946171A (zh) * 2007-12-14 2011-01-12 拜奥蒂乌姆股份有限公司 荧光化合物
CN103328532A (zh) * 2010-01-19 2013-09-25 赛里根Ii有限公司 用于定向生物标志信号放大的新颖试剂
CN102692508A (zh) * 2012-04-28 2012-09-26 广州鸿琪光学仪器科技有限公司 一种快速定量检测肌钙蛋白t的免疫荧光试纸条组件及其制成的检测卡组件和制备方法
US20140206099A1 (en) * 2012-09-18 2014-07-24 Biotium, Inc. Methods, compositions and kits for labeling of proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
STEVE KNUTSON 等: "Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer", 《PLOS ONE》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113913404A (zh) * 2020-07-10 2022-01-11 上海米然生物科技有限公司 一种荧光交联RNase H突变体缀合物及其应用
WO2023088402A1 (zh) * 2021-11-22 2023-05-25 菲鹏生物股份有限公司 一种捕获法检测抗体的方法和应用

Also Published As

Publication number Publication date
EP3507603C0 (en) 2024-03-06
ES2979129T3 (es) 2024-09-24
JP2026071206A (ja) 2026-04-28
US20240042062A1 (en) 2024-02-08
WO2018045278A1 (en) 2018-03-08
US20200261602A1 (en) 2020-08-20
JP2025028883A (ja) 2025-03-05
US20200330610A1 (en) 2020-10-22
JP2019531474A (ja) 2019-10-31
US20180092993A1 (en) 2018-04-05
JP7216638B2 (ja) 2023-02-01
EP3507603B1 (en) 2024-03-06
US11865191B2 (en) 2024-01-09
JP2023025018A (ja) 2023-02-21
US11857643B2 (en) 2024-01-02
EP4425179A3 (en) 2024-12-11
EP4425179A2 (en) 2024-09-04
EP3507603A1 (en) 2019-07-10

Similar Documents

Publication Publication Date Title
US20240042062A1 (en) Compositions and methods for enhanced fluorescence
JP7097885B2 (ja) 水溶性ポリマー色素
EP3775052A1 (en) Water-soluble polymeric dyes having pendant chromophores
WO2018009581A1 (en) Fluorescent water-solvated conjugated polymers
EP3481900A1 (en) Blue-excitable water-solvated polymeric dyes
WO2022216449A1 (en) Water-soluble yellow green absorbing dyes
ES2542337T3 (es) Direccionamiento y seguimiento de antígenos en células vivas
ES2902888T3 (es) Proteína Rep mejorada para su uso en un ensayo diagnóstico
WO2016139643A9 (en) Molecular sensors
WO2020222894A1 (en) Water-soluble polynorbornene dyes having pendant chromophores
EP4155349A1 (en) Water-soluble yellow green absorbing dyes
EP3830126A1 (fr) Anticorps a domaine unique qui se lient a la proteine g alpha
EP4634306A1 (en) Sulfonate-containing water-solubilizing peptides
EP4267679A1 (en) Water-soluble yellow green absorbing dyes
AU2023238650A1 (en) Violet excitable tandem dyes, and methods for making and using the same
CN111471686A (zh) 一种靶向p53蛋白的寡核苷酸序列及其衍生探针和应用
Srivastava Development of Chemical Proteomic Approaches to Study Viral Endocytosis and Phosphoproteomics
CN119119229A (zh) 非天然氨基酸及其作为探针的应用
KR20200041713A (ko) 인공결합쌍을 이용한 단백질 검출 방법 및 검출용 키트
JP2008208079A (ja) タンパク質架橋試薬セット

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination